Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant role (Expand Search), significant risks (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant rates » significant facies (Expand Search), significant role (Expand Search), significant risks (Expand Search)
rates decrease » rate decreased (Expand Search), greatest decrease (Expand Search), greater decrease (Expand Search)
-
3441
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
3442
-
3443
Combination therapy exhibited apoptosis in Ba/F3 EML4-ALKmutant cell models.
Published 2025Subjects: -
3444
-
3445
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
3446
-
3447
-
3448
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3449
-
3450
-
3451
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
3452
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3453
-
3454
-
3455
Ba/F3 EML4-ALK<sup>mutants</sup> exhibit variable dose-response to ABT-199 treatment.
Published 2025Subjects: -
3456
-
3457
-
3458
-
3459
-
3460